Navigation Links
Haemacure Update on Proposed Collaboration and Bridge Financing
Date:5/22/2009

In such event, a portion of the loan will be converted into another type of Haemacure security, as agreed to at that time by Angiotech and Haemacure. Angiotech has an option to advance to Haemacure on the day immediately preceding the closing of such equity financing all draw-downs that have not previously been advanced to Haemacure, to the maximum amount of US$2.5 million. In the event of the conversion of the loan into shares, Angiotech will be entitled to one seat on Haemacure's Board of Directors. In the event that there is no such equity financing, the principal amount of the loan and all accrued interest will be payable by Haemacure upon the loan's maturity.

Upon the closing, if any, of the equity financing by Haemacure, it will issue a warrant to Angiotech exercisable for the same type of security as that issued by Haemacure in the equity financing. The warrant will: (i) be exercisable for a number of Haemacure securities arrived at by dividing 100% of the loan amount plus accrued interest by the issue price of the equity financing; (ii) have an exercise price equal to the issue price of the equity financing; and (iii) have a term equal to the term of warrants, if any, issued in the equity financing. In the event that no warrants are issued by Haemacure in the equity financing, the warrant issued to Angiotech will have a term of five years from the date of closing of the equity financing.

Haemacure and Angiotech are also preparing definitive collaboration agreements under which Angiotech will have certain license and distribution rights to Haemacure's fibrin sealant and thrombin. It is expected that the collaboration agreements will be signed on or about June 1, 2009.

Completion of the transaction is conditional on standard closing conditions, including final negotiation and execution of loan and security documentation and the related collaboration agreements. Haemacure can give no assurance that the various closing conditions will be
'/>"/>

SOURCE Haemacure Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Haemacure Signs Term Sheet for Proposed Collaboration and Bridge Financing
2. Haemacure Reports First Quarter 2009 Results and Hires Advisor for the Sale or Merger of the Company
3. Haemacure Restructures - Seeks Financing or Sale of the Company
4. Haemacure to Present at the 11th Annual BIO CEO & Investor Conference
5. Haemacure Announces Fiscal 2008 Results
6. Haemacures Human Fibrin Sealant Demonstrates Effectiveness in Skin Graft Fixation Proof-of-Concept Study for Burn Injury
7. Haemacure Confirms Operation Qualification of Production Equipment and Pursues Milestone Payment from CSL
8. Haemacure to Present at the Rodman & Renshaw Annual Global Investor Conference
9. Haemacure Appoints Thomas J. Lynch, J.D., Ph.D. to Board of Directors
10. Adhesion Prevention New Major Market Opportunity, Haemacure Confirms Effectiveness of its Fibrin Sealant in Second Preclinical Study in Adhesion Prevention in a Bleeding Model
11. Haemacure Raises $7.8 Million and is Fully Funded Beyond First-Patient-In-Clinic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... The Canton Group, a leading web ... announced today that Tim Dodge has joined the company ... The Canton Group as it implements an ambitious ... , Tim is a tech industry veteran who has ... technology companies. Before joining The Canton Group, Tim was ...
(Date:6/3/2015)... 2015 Follow us on LinkedIn ... revolutionized disease treatment on account of their better mode ... such as rheumatoid arthritis. The industry is expected to ... small molecule drugs to biopharmaceuticals over the coming years. ... and gene therapies, and recombinant proteins has attracted industry ...
(Date:6/3/2015)... Vancouver personal injury lawyers at Jiwa ... now handle personal injury claims resulting due to bus ... more and more people turn towards mass transportation for ... suffering, serious injury and also deaths. , “If ... accident in BC you may have an ICBC Claim,” ...
(Date:6/3/2015)... Array Health , a leading provider of ... Jonathan Rickert will present at America’s Health Insurance ... The session will address the how the rise of ... in health care, and why they are critical to ... and the Health Care Enterprise: Driving Business Value ...
(Date:6/3/2015)... 03, 2015 A group of nine ... with a Global Inspire Award at DIA’s upcoming Annual ... outstanding volunteers for their leadership, level of excellence, and ... , The recipients of the Author(s) of the Year ... whose article has made a significant impact in advancing ...
Breaking Medicine News(10 mins):Health News:The Canton Group Appoints Tim Dodge as Chief Marketing Officer 2Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Jiwa Law Corporation Now Handles Personal Injury Claims Involving Bus Accidents 2Health News:Array Health’s CEO to Present at America’s Health Insurance Plans Institute 2015 2Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 2Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 3Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 4
... to avoid harm , , FRIDAY, April 10 (HealthDay News) -- ... recipe for disaster. , The Soap and Detergent Association ... a more effective cleaner, you might be creating a safety ... those made with natural products, could cause harm to the ...
... and mercury exposure , , SATURDAY, April 11 (HealthDay News) -- ... for optimal maternal health and fetal growth and development. That ... how much seafood moms-to-be can safely consume without exposing their ... of ongoing debate. , The U.S. Food and Drug ...
... Manager online scheduling systems during the first quarter of 2009. , ... ... of Aladtec Inc.), a leader in online employee scheduling solutions for the ... and FIRE Manager customers: , , ,Madison County EMS (VA) ,Lehi Fire ...
... April 11 Following is the daily "Profile America" ... http://www.newscom.com/cgi-bin/prnh/20090226/CENSUSLOGO ) SATURDAY, APRIL 11: DONATE LIFEProfile ... month of spring and resurgence. It,s also National ... donation to give a new lease on life to ...
... Ala. Researchers at the University of Alabama at ... $6.4 million grant from two national nonprofit groups that ... difficult-to-treat form of cancer called "triple negative" breast cancer. ... the Cure and the Triple Negative Breast Cancer Foundation. ...
... can have an impact on patients, experts say , , ... emotional burnout called "compassion fatigue" is common among doctors, ... with cancer, yet experts say little research has been ... cynicism, chronic tiredness, irritability and problem drinking. , Often ...
Cached Medicine News:Health News:Cleaning Concoctions Best Left to Experts 2Health News:How Much Fish to Eat While Pregnant? 2Health News:How Much Fish to Eat While Pregnant? 3Health News:Aladtec Inc Announces New Customers for Online Scheduling Systems -- First Quarter, 2009 2Health News:UAB wins $6.4 million nonprofit grant to fight aggressive breast cancer 2Health News:Stressed Health Care Workers Battle 'Compassion Fatigue' 2Health News:Stressed Health Care Workers Battle 'Compassion Fatigue' 3
(Date:6/3/2015)... -- According to a new market ... Market (Embolic Protection, Chronic Total Occlusion, Atherectomy, Thrombectomy, ... Stents, Balloons and Accessories) - Forecasts to 2019 ", ... Vascular Devices Market is expected to reach around ... 7.4% from 2014 to 2019. ...
(Date:6/3/2015)... 2015  Essential Medical, Inc., a privately held medical ... to speak at the 2015 Jefferies Global Healthcare Conference ... June 4th.  The company will present ... review of first in human results on both the ... femoral arterial punctures made during cardiac catheterization procedures such ...
(Date:6/3/2015)... 3, 2015 RXi Pharmaceuticals Corporation ... focused on discovering and developing innovative therapeutics, ... ophthalmology, today announced that it received a Notice ... and Trademark Office (USPTO) on its novel, ... "RNA Interference in Ocular Indications," covers methods ...
Breaking Medicine Technology:The Interventional Cardiology and Peripheral Vascular Devices Market Worth $26.72 Billion by 2019 2The Interventional Cardiology and Peripheral Vascular Devices Market Worth $26.72 Billion by 2019 3The Interventional Cardiology and Peripheral Vascular Devices Market Worth $26.72 Billion by 2019 4Essential Medical Inc. Announces Participation in 2015 Jefferies Global Healthcare Conference - NYC 2RXi Pharmaceuticals Granted Notice of Allowance for Patent Covering Lead Compound, RXI-109, for Use in the Eye 2RXi Pharmaceuticals Granted Notice of Allowance for Patent Covering Lead Compound, RXI-109, for Use in the Eye 3RXi Pharmaceuticals Granted Notice of Allowance for Patent Covering Lead Compound, RXI-109, for Use in the Eye 4
... Oct. 21 Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: ... Shareholders held on Tuesday, October 20, 2009. , At the ... Mundinger, and Dr. Jack W. Singer to serve on the ... approved the proposals to increase the number of shares available ...
... SARATOGA, Calif., Oct. 20 VisionCare Ophthalmic Technologies, ... for individuals with age-related macular degeneration (AMD), today ... implantable telescope technology. VisionCare,s investigational telescope implant is ... FDA approval by the FDA Ophthalmic Devices Advisory ...
Cached Medicine Technology:Cell Therapeutics, Inc. Reports Outcome of Annual Meeting of Shareholders 2VisionCare Implantable Telescope Technology Presentations Featured at Upcoming American Academy of Ophthalmology and Ophthalmology Innovation Summit Meetings 2VisionCare Implantable Telescope Technology Presentations Featured at Upcoming American Academy of Ophthalmology and Ophthalmology Innovation Summit Meetings 3
Egg-Shaped Bioceramic orbital implants insert easily into orbital socket and will not cling to surrounding tissue. Improved interconnectivity between pores enhances vascularization. Implants may be e...
... Discrete Technology Coronary Stent System provides ... Secure Technology stent retention system features ... encapsulate the stent for added security ... to minimize balloon overhang and to ...
Increased stent scaffolding at the proximal end gives optimal lumen support and 6F guide catheter compatibility and improved tracking offer excellent deliverability. Customized balloon lengths for ea...
For support, strength and control in your interventions, the RunWay Guide Catheter's large lumen and high-performance design represents a new era in guide catheters....
Medicine Products: